Abbott Laboratories Current Ratio 2010-2025 | ABT

Current and historical current ratio for Abbott Laboratories (ABT) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Abbott Laboratories current ratio for the three months ending March 31, 2025 was 1.78.
Abbott Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $23.15B $13.00B 1.78
2024-12-31 $23.66B $14.16B 1.67
2024-09-30 $23.80B $14.90B 1.60
2024-06-30 $23.12B $13.76B 1.68
2024-03-31 $22.38B $14.02B 1.60
2023-12-31 $22.67B $13.84B 1.64
2023-09-30 $22.66B $13.04B 1.74
2023-06-30 $23.51B $14.35B 1.64
2023-03-31 $24.38B $14.53B 1.68
2022-12-31 $25.22B $15.49B 1.63
2022-09-30 $24.85B $13.37B 1.86
2022-06-30 $24.96B $12.39B 2.01
2022-03-31 $23.43B $12.65B 1.85
2021-12-31 $24.24B $13.11B 1.85
2021-09-30 $23.49B $12.87B 1.83
2021-06-30 $22.63B $12.61B 1.79
2021-03-31 $21.82B $12.46B 1.75
2020-12-31 $20.44B $11.91B 1.72
2020-09-30 $17.39B $10.26B 1.70
2020-06-30 $17.22B $10.96B 1.57
2020-03-31 $15.50B $10.81B 1.43
2019-12-31 $15.67B $10.86B 1.44
2019-09-30 $16.12B $10.49B 1.54
2019-06-30 $15.20B $9.06B 1.68
2019-03-31 $14.41B $9.11B 1.58
2018-12-31 $14.63B $9.01B 1.62
2018-09-30 $18.20B $12.78B 1.42
2018-06-30 $14.12B $8.95B 1.58
2018-03-31 $14.96B $9.01B 1.66
2017-12-31 $20.15B $8.91B 2.26
2017-09-30 $21.38B $7.94B 2.69
2017-06-30 $19.98B $6.80B 2.94
2017-03-31 $19.33B $6.65B 2.91
2016-12-31 $26.78B $6.66B 4.02
2016-09-30 $12.98B $8.32B 1.56
2016-06-30 $12.99B $8.67B 1.50
2016-03-31 $12.41B $8.39B 1.48
2015-12-31 $14.16B $9.19B 1.54
2015-09-30 $15.89B $8.76B 1.82
2015-06-30 $21.13B $9.19B 2.30
2015-03-31 $19.99B $9.21B 2.17
2014-12-31 $13.56B $10.47B 1.30
2014-09-30 $16.46B $10.82B 1.52
2014-06-30 $18.26B $9.85B 1.85
2014-03-31 $17.93B $10.19B 1.76
2013-12-31 $19.25B $9.51B 2.03
2013-09-30 $19.75B $11.33B 1.74
2013-06-30 $19.83B $10.92B 1.82
2013-03-31 $19.10B $10.41B 1.84
2012-12-31 $31.32B $13.28B 2.36
2012-09-30 $27.26B $16.29B 1.67
2012-06-30 $26.26B $17.12B 1.53
2012-03-31 $25.60B $16.79B 1.53
2011-12-31 $23.77B $15.48B 1.54
2011-09-30 $23.09B $15.41B 1.50
2011-06-30 $24.13B $15.84B 1.52
2011-03-31 $23.65B $17.23B 1.37
2010-12-31 $22.32B $17.26B 1.29
2010-09-30 $19.45B $15.58B 1.25
2010-06-30 $19.92B $14.69B 1.36
2010-03-31 $17.69B $15.18B 1.17
2009-12-31 $23.31B $13.05B 1.79
2009-09-30 $21.42B $12.53B 1.71
2009-06-30 $19.63B $12.04B 1.63
2009-03-31 $18.01B $11.77B 1.53
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $232.407B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $151.037B 37.81
Stryker (SYK) United States $146.527B 30.64
EssilorLuxottica (ESLOY) France $129.703B 0.00
Medtronic (MDT) Ireland $112.146B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.313B 0.00
Haleon (HLN) United Kingdom $49.844B 28.38
ResMed (RMD) United States $36.979B 27.78
Agilent Technologies (A) United States $32.895B 21.44
GE HealthCare Technologies (GEHC) United States $32.794B 15.57
Terumo (TRUMY) Japan $26.561B 34.50
Koninklijke Philips (PHG) Netherlands $22.051B 15.85
Insulet (PODD) United States $21.941B 86.12
Zimmer Biomet Holdings (ZBH) United States $18.277B 11.74
Baxter (BAX) United States $15.529B 11.59
Smith & Nephew SNATS (SNN) United Kingdom $13.253B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Sunny Optical Technology (SNPTF) China $8.430B 0.00
Bio-Rad Laboratories (BIO) United States $5.971B 20.78
Lantheus Holdings (LNTH) United States $5.642B 14.23
Prestige Consumer Healthcare (PBH) United States $4.203B 18.78
Perrigo (PRGO) Ireland $3.596B 9.11
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.385B 15.42
ICU Medical (ICUI) United States $3.275B 24.15
Envista Holdings (NVST) United States $3.174B 26.38
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $1.997B 13.73
LeMaitre Vascular (LMAT) United States $1.901B 42.49
AtriCure (ATRC) United States $1.730B 0.00
Acuren (TIC) United States $1.271B 0.00
AdaptHealth (AHCO) United States $1.201B 12.19
Neogen (NEOG) United States $1.131B 14.47
BioLife Solutions (BLFS) United States $1.126B 0.00
Green Thumb Industries (GTBIF) United States $1.100B 24.74
Kestra Medical Technologies (KMTS) United States $1.063B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.895B 9.02
Capricor Therapeutics (CAPR) United States $0.650B 0.00
Evolus (EOLS) United States $0.647B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Owens & Minor (OMI) United States $0.619B 5.13
Maravai LifeSciences Holdings (MRVI) United States $0.609B 0.00
Curaleaf Holdings (CURLF) Canada $0.584B 0.00
Valneva SE (VALN) France $0.515B 0.00
Surmodics (SRDX) United States $0.420B 0.00
Tilray Brands (TLRY) Canada $0.408B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.76
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.322B 57.20
Canopy Growth (CGC) Canada $0.313B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.289B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Cresco Labs (CRLBF) United States $0.265B 0.00
Sanara MedTech (SMTI) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.261B 11.87
Sanuwave Health (SNWV) United States $0.239B 0.00
Omeros (OMER) United States $0.221B 0.00
OraSure Technologies (OSUR) United States $0.216B 0.00
Biote (BTMD) United States $0.210B 5.89
Quanterix (QTRX) United States $0.209B 0.00
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Brainsway (BWAY) Israel $0.197B 52.25
High Tide (HITI) Canada $0.193B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.86
Organigram Global (OGI) Canada $0.181B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.139B 0.00
FitLife Brands (FTLF) United States $0.134B 16.54
Jin Medical (ZJYL) China $0.120B 0.00
MacroGenics (MGNX) United States $0.112B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.59
Quipt Home Medical (QIPT) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.038B 13.14
Nephros (NEPH) United States $0.036B 48.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00